search
Back to results

Functional Orthosis Versus Cast Immobilization for Partially Unstable Weber B Ankle Fractures

Primary Purpose

Ankle Fractures

Status
Recruiting
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Functional orthosis
Cast immobilization
Sponsored by
Ostfold Hospital Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ankle Fractures focused on measuring Weber B, SER4a

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients:
  • With isolated Weber type B fractures that are deemed stable on weightbearing radiographs (MCS injured ankle - MCS uninjured ankle < 1 mm).
  • With concomitant gravity stress test evaluated as unstable (MCS injured ankle - MCS uninjured ankle < 1 mm)
  • Presenting to one of the participating hospitals, and that are available for stability evaluation within 14 days after injury.
  • 18-80 years of age
  • With pre-injury walking ability without aids.

Exclusion Criteria:

  • Patients:
  • with fracture of the medial malleolus, pre-hospital closed fracture reduction, open fracture, fracture resulting from high-energy trauma or multi-trauma or pathologic fracture.
  • with fracture of the posterior malleolus involving 25% or more of the joint surface or with a step of the intraarticular surface. (non-displaced fractures smaller than 25% can be included)
  • with neuropathies and generalized joint disease such as Rheumatoid Arthritis.
  • that are assumed not compliant (drug use, cognitive- and/or psychiatric disorders).
  • with previous history of ipsilateral ankle fracture.
  • with previous history of ipsilateral major ankle-/foot surgery.
  • who live outside one of the participating hospitals catchment areas (not available for follow-up).

Sites / Locations

  • Sykehuset Innlandet, GjøvikRecruiting
  • Ålesund HospitalRecruiting
  • Østfold Hospital TrustRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Functional orthosis

Cast immobilization

Arm Description

Use of a functional orthosis device (AirCast Air-Stirrup) for 6 weeks. Weightbearing as tolerated will be allowed in both groups immediately after application of the cast or orthosis.

Use of a below-the-knee cast circular cast (3M scotch cast) for 6 weeks.

Outcomes

Primary Outcome Measures

Change from 6 weeks Manchester-Oxford Foot and Ankle Questionnaire score at 2 years
Scale 0-100, lower scores indicate less pain and symptoms.

Secondary Outcome Measures

Change from 6 weeks Olerud Molander Ankle Score at 2 years
Scale 0-100, higher scores indicate less pain and symptoms.
Numeric rating scale of of patient satisfaction with treatment protocol
A 0-10 rating scale for perceived satisfaction with orthosis or cast
Change from baseline tibiotalar congruity at 2 years
Measurement of ankle medial clear space from weightbearing and gravity stress ankle radiographs
Registrations of complications/adverse events
Registration of possible loss of congruence, delayed union, non-union, thromboembolic events
Change from 6 weeks ankle range of motion at 2 years
Measurement using a goniometer (ad modum Lindsjø)

Full Information

First Posted
May 6, 2022
Last Updated
January 27, 2023
Sponsor
Ostfold Hospital Trust
Collaborators
Alesund Hospital, Sykehuset Innlandet HF
search

1. Study Identification

Unique Protocol Identification Number
NCT05412693
Brief Title
Functional Orthosis Versus Cast Immobilization for Partially Unstable Weber B Ankle Fractures
Official Title
Six Weeks Functional Orthosis Versus Cast Immobilization for Partially Unstable Weber B/SER4a Ankle Fractures - a Multicenter Randomized Non-inferiority Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 15, 2022 (Actual)
Primary Completion Date
December 31, 2025 (Anticipated)
Study Completion Date
December 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ostfold Hospital Trust
Collaborators
Alesund Hospital, Sykehuset Innlandet HF

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Stability dictates treatment choice for trans-syndesmotic fibula fractures. Optimal treatment for partially unstable fractures remains a topic of debate. The purpose of this study is to evaluate possible outcome non-inferior of functional orthosis treatment versus cast immobilization for these fractures.
Detailed Description
Evidence suggests that Weber B ankle fractures should be treated nonoperatively if the ankle mortise is stable. Stability is maintained if the deltoid ligament is intact, also known as a Weber B/SER2 injury. Functional orthosis treatment is advised for these injuries. Recently, authors have demonstrated that the fractured ankle can be functionally stable even with a partial deltoid ligament injury. Our interpretation of a partial deltoid ligament injury is when weightbearing radiographs indicate stability (no increase in medial clear space), while concomitant gravity stress radiographs indicate instability (due to increase in medial clear space). It is suggested that this is referred to as a Weber B/SER4a injury. Although now considered for nonoperative treatment, partially unstable/SER4a injuries were traditionally treated operatively. Today, the superiority of one method of nonoperative treatment over another for partially unstable/SER4a injuries remains unclear. Some authors advocate cast immobilization while others have shown good outcomes after inconsistently using different orthoses and cast devices. The argument for cast immobilization appears to be a fear of posttraumatic osteoarthritis because of potential recurrent instability. As a result, cast immobilization of partially unstable/SER4a fractures is implemented in reference European guidelines, and thus must be considered the reference treatment. To our knowledge, no study has documented increased prevalence of osteoarthritis associated with functional treatment of partially unstable/SER4a fractures. The use of cast immobilization remains a precautionary principle, but the choice is not so clear cut because cast immobilization comes with an increased risk of joint stiffness and thromboembolic complications. Long-term radiographic and patient-reported outcome data evaluating possible non-inferiority of functional orthosis treatment compared to cast immobilization will assist in guiding future treatment strategies of these common fractures.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ankle Fractures
Keywords
Weber B, SER4a

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Masking Description
Masking is not possible during the first 6 weeks of treatment due to the nature of the interventions. Investigators and outcome assessors will be masked for follow-up after 6 weeks.
Allocation
Randomized
Enrollment
110 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Functional orthosis
Arm Type
Experimental
Arm Description
Use of a functional orthosis device (AirCast Air-Stirrup) for 6 weeks. Weightbearing as tolerated will be allowed in both groups immediately after application of the cast or orthosis.
Arm Title
Cast immobilization
Arm Type
Active Comparator
Arm Description
Use of a below-the-knee cast circular cast (3M scotch cast) for 6 weeks.
Intervention Type
Device
Intervention Name(s)
Functional orthosis
Intervention Description
See arm descriptions
Intervention Type
Device
Intervention Name(s)
Cast immobilization
Intervention Description
See arm descriptions
Primary Outcome Measure Information:
Title
Change from 6 weeks Manchester-Oxford Foot and Ankle Questionnaire score at 2 years
Description
Scale 0-100, lower scores indicate less pain and symptoms.
Time Frame
6 weeks, 2 years
Secondary Outcome Measure Information:
Title
Change from 6 weeks Olerud Molander Ankle Score at 2 years
Description
Scale 0-100, higher scores indicate less pain and symptoms.
Time Frame
6 weeks, 2 years
Title
Numeric rating scale of of patient satisfaction with treatment protocol
Description
A 0-10 rating scale for perceived satisfaction with orthosis or cast
Time Frame
6 weeks
Title
Change from baseline tibiotalar congruity at 2 years
Description
Measurement of ankle medial clear space from weightbearing and gravity stress ankle radiographs
Time Frame
Baseline, 2 years
Title
Registrations of complications/adverse events
Description
Registration of possible loss of congruence, delayed union, non-union, thromboembolic events
Time Frame
2 years
Title
Change from 6 weeks ankle range of motion at 2 years
Description
Measurement using a goniometer (ad modum Lindsjø)
Time Frame
6 weeks, 2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients: With isolated Weber type B fractures that are deemed stable on weightbearing radiographs (MCS injured ankle - MCS uninjured ankle < 1 mm). With concomitant gravity stress test evaluated as unstable (MCS injured ankle - MCS uninjured ankle < 1 mm) Presenting to one of the participating hospitals, and that are available for stability evaluation within 14 days after injury. 18-80 years of age With pre-injury walking ability without aids. Exclusion Criteria: Patients: with fracture of the medial malleolus, pre-hospital closed fracture reduction, open fracture, fracture resulting from high-energy trauma or multi-trauma or pathologic fracture. with fracture of the posterior malleolus involving 25% or more of the joint surface or with a step of the intraarticular surface. (non-displaced fractures smaller than 25% can be included) with neuropathies and generalized joint disease such as Rheumatoid Arthritis. that are assumed not compliant (drug use, cognitive- and/or psychiatric disorders). with previous history of ipsilateral ankle fracture. with previous history of ipsilateral major ankle-/foot surgery. who live outside one of the participating hospitals catchment areas (not available for follow-up).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Martin Gregersen
Phone
48171718
Email
martinggregersen@gmail.com
Facility Information:
Facility Name
Sykehuset Innlandet, Gjøvik
City
Gjøvik
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nicolaj Quist Gill
Email
Nicolaj.Emil.Quist.Gill@sykehuset-innlandet.no
First Name & Middle Initial & Last Name & Degree
Håvard Furunes
Email
havardfurunes@gmail.com
Facility Name
Ålesund Hospital
City
Ålesund
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ragnhild Justad-Berg
Email
ragnhild.therese.justad-berg@helse-mr.no
First Name & Middle Initial & Last Name & Degree
Lars Kjetil Aas
Email
Lars.Kjetil.Aas@helse-mr.no
Facility Name
Østfold Hospital Trust
City
Sarpsborg
State/Province
Østfold
ZIP/Postal Code
1714
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Martin Greger Gregersen, PhD candidate
Phone
+4748171718
Email
martingjohansen@gmail.com
First Name & Middle Initial & Last Name & Degree
Marius Molund, PhD
Phone
+4790093988
Email
marius.molund@so-hf.no

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Functional Orthosis Versus Cast Immobilization for Partially Unstable Weber B Ankle Fractures

We'll reach out to this number within 24 hrs